Humanised mice: immunotherapy and regenerative medicine

Course overview

Humanized mouse engraftment models (human immune system and/or human tissue) are an integral part of basic and translational research for the understanding of human diseases and for development of new therapies. The Ebola Virus outbreak has demonstrated the relevance of humanized mouse models for the understanding of emerging diseases and testing new medicines. The same can apply for the Coronavirus (COVID-19) pandemic. “Big pharma” and biotech companies include humanized mice in their pre-clinical development portfolio to test efficacy and safety of anti-cancer drugs. These platforms provide researchers and drug developers with human specific targets, physiological pathways and mechanisms of disease not found in traditional mouse models of disease. These aspects of the humanized models allow direct testing of human versus mouse specific therapies enabling more rapid drug development and the generation of more clinically relevant data. During the last decade these models have substantially diverged among laboratories regarding the mouse strains used, mouse handling, analyses techniques and sources of human material. This experimental variability is expected as the field is dynamic and growing rapidly, but the data documentation and reporting should be better standardized for metadata analyses.

This course will teach the participants the principles of experimental pre-requisites and harmonized analyses (e.g., flow cytometry, RNA sec and genomic analyses).

What past participants say about the course

“The course was a great professional investment and a unique opportunity to make new contacts, learn from experts, be inspired, and learn a lot. I highly recommend this course!” – Priscila Pini Zenatti, Boldrini Children Hospital, Brazil

“The course on humanised mice gave me the opportunity to meet and connect with young and established researchers in the field. Not only could I gain valuable feedback on my work as well as the humanised mouse model, but also connect with the research community and strengthen my skills.” – Lisa Rieble, University of Zürich, Switzerland

Please see EMBL’s COVID-19 safety recommendations for testing and other requirements to attend this on-site course.

Warning

EMBL wishes to warn sponsors of EMBL conferences and courses of fraudulent schemes purporting to offer sponsorship opportunities on behalf of EMBL or affiliated with EMBL officials. One current scam campaign of which we are aware is conducted using the name ‘Judy Eastman’ (judy@gopcontact.a2hosted.com) and entails approaches to sponsors offering sponsorship opportunities on EMBL’s behalf. Please be kindly advised that all relevant communication regarding sponsorship of EMBL conferences, symposia and courses is handled by EMBL directly and is sent from an official EMBL account. EMBL does not work with any external providers on sponsorship acquisition.

Please also note that:

EMBL never provides attendee lists for purchase. Any offers of such are fraudulent.
EMBL will never call or email you to ask for your credit card details or to request a payment.
All payments are on invoice.

Suspicious communications purportedly from, for or on behalf of EMBL should be reported to EMBL at the following email address sponsorship@embl.de.